Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

GIANVI vs GLATIRAMER: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

GIANVI vs GLATIRAMER: Safety Overview

Metric GIANVI GLATIRAMER
Total FAERS Reports 212 46,357
Deaths Reported 2 696
Death Rate 0.9% 1.5%
Hospitalizations 86 5,831
Average Patient Age 30.1 yrs 48.4 yrs
% Female Patients N/A 81.0%
FDA Approval Date N/A Apr 16, 2015
Manufacturer N/A Zydus Pharmaceuticals USA Inc.
Route N/A SUBCUTANEOUS
Marketing Status N/A Discontinued